Abstract
QseC is a histidine kinase (HK) receptor involved in quorum sensing, a mechanism by which bacteria respond to fluctuations in cell population. We conducted a structural study of the cytoplasmic domain of QseC (QseC-CD) using X-ray crystallography. The 2.5 Å structure of the apo-enzyme revealed that the kinase domain of QseC retains the overall fold of the typical HK kinase domain. The construct that we used is inactive in the autokinase reaction and its inactivity is most likely caused by its atypical dimerization interface, as compared to that observed in the T.maritima HK cytoplasmic domain structure. Restoration of the activity may require that the entire dimerization domain be present in the protein construct. QseC, which plays an important role in bacterial pathogenesis, is a promising drug target and the structure of QseCCD provides a platform for developing more potent inhibitors of pathogen virulence.
Keywords: Cytoplasmic domain, histidine kinase, phosphorylation, quorum sensing, response regulator, two-component regulatory systems, domain, histidine, quorum, response, two-component, systems, Virulence†, (HK), X-ray crystallography, T.maritima, (RR), (TM1), (TM2), (DHp), (CA), ATP, HAMP, HK/RRs, (EPI/NEI), flhDC, E.coli E22, HK853-CD), (NCS), PyMOL, melittin, DMPC, DLS, Gel-electrophoresis, Nucleotide, Crystal Packi, PISA server, S.typhimurium
Protein & Peptide Letters
Title: Structure of the Cytoplasmic Segment of Histidine Kinase Receptor QseC: A Key Player in Bacterial Virulence
Volume: 17 Issue: 11
Author(s): Wei Xie, Chris Dickson, Witek Kwiatkowski and Senyon Choe
Affiliation:
Keywords: Cytoplasmic domain, histidine kinase, phosphorylation, quorum sensing, response regulator, two-component regulatory systems, domain, histidine, quorum, response, two-component, systems, Virulence†, (HK), X-ray crystallography, T.maritima, (RR), (TM1), (TM2), (DHp), (CA), ATP, HAMP, HK/RRs, (EPI/NEI), flhDC, E.coli E22, HK853-CD), (NCS), PyMOL, melittin, DMPC, DLS, Gel-electrophoresis, Nucleotide, Crystal Packi, PISA server, S.typhimurium
Abstract: QseC is a histidine kinase (HK) receptor involved in quorum sensing, a mechanism by which bacteria respond to fluctuations in cell population. We conducted a structural study of the cytoplasmic domain of QseC (QseC-CD) using X-ray crystallography. The 2.5 Å structure of the apo-enzyme revealed that the kinase domain of QseC retains the overall fold of the typical HK kinase domain. The construct that we used is inactive in the autokinase reaction and its inactivity is most likely caused by its atypical dimerization interface, as compared to that observed in the T.maritima HK cytoplasmic domain structure. Restoration of the activity may require that the entire dimerization domain be present in the protein construct. QseC, which plays an important role in bacterial pathogenesis, is a promising drug target and the structure of QseCCD provides a platform for developing more potent inhibitors of pathogen virulence.
Export Options
About this article
Cite this article as:
Xie Wei, Dickson Chris, Kwiatkowski Witek and Choe Senyon, Structure of the Cytoplasmic Segment of Histidine Kinase Receptor QseC: A Key Player in Bacterial Virulence, Protein & Peptide Letters 2010; 17 (11) . https://dx.doi.org/10.2174/0929866511009011383
DOI https://dx.doi.org/10.2174/0929866511009011383 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of a Tetrasaccharide Present in Motif B of the Mycobacterium tuberculosis Cell Wall
Letters in Organic Chemistry TNF-α and Ghrelin: Opposite Effects on Immune System, Metabolism and Mental Health
Protein & Peptide Letters Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics Polymer Particulates in Drug Delivery
Current Pharmaceutical Design Identification and Investigation of Chalcone Derivatives as Calcium Channel Blockers: Pharmacophore Modeling, Docking Studies, In vitro Screening, and 3D-QSAR Analysis
Current Computer-Aided Drug Design Disseminated TB in an Immunocompetent Patient: A Case Report
Infectious Disorders - Drug Targets Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
Current Signal Transduction Therapy Comparative Protein Profiling of Intraphagosomal Expressed Proteins of Mycobacterium bovis BCG
Protein & Peptide Letters Biochemical Aspects of Nitric Oxide
Current Pharmaceutical Design Recent Achievements on Siderophore Production and Application
Recent Patents on Biotechnology Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
Current Molecular Pharmacology Applications of Docking and Molecular Dynamic Studies on the Search for New Drugs Against the Biological Warfare Agents Bacillus anthracis and Yersinia pestis
Current Computer-Aided Drug Design CuAAC Click Chemistry Accelerates the Discovery of Novel Chemical Scaffolds as Promising Protein Tyrosine Phosphatases Inhibitors
Current Medicinal Chemistry Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Using Property Based Sequence Motifs and 3D Modeling to Determine Structure and Functional Regions of Proteins
Current Medicinal Chemistry Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases
Coronaviruses Phytol a Natural Diterpenoid with Pharmacological Applications on Central Nervous System: A Review
Recent Patents on Biotechnology Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report
Current Drug Safety Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy The Role of Intrinsically Disordered Regions in the Structure and Functioning of Small Heat Shock Proteins
Current Protein & Peptide Science